logo

Sorrento Therapeutics, Inc. (SRNE)



Trade SRNE now with
  Date
  Headline
5/26/2020 9:10:41 AM Sorrento Therapeutics Receives FDA Clearance For Investigational New Drug Application For STI-6129
5/15/2020 11:03:28 AM Sorrento Says Anti-SARS-CoV-2 Antibody, STI-1499, Shows 100% Inhibition Of SARS-CoV-2 Virus Infection; Stock Surges
5/8/2020 9:24:10 AM Sorrento And Mount Sinai Health System To Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection
1/27/2020 7:06:19 AM Sorrento Therapeutics Unanimously Rejects Recent Acquisition Proposal
1/10/2020 7:04:44 AM Sorrento Therapeutics Gets Non-binding Proposal From A Private Equity Fund To Buy Shares Of The Company For Up To $7/Shr
1/6/2020 7:12:46 AM Sorrento: Mabpharm File NDA For Infliximab Biosimilar Antibody In China
12/16/2019 7:19:52 AM Sorrento Therapeutics Adds Robin Smith To Its Board
11/25/2019 7:05:01 AM Sorrento Therapeutics Reports Receipt Of Acquisition Proposal; Rejects Offer
10/15/2019 11:02:10 PM Los Angeles Court Rejects Patrick Soon-Shiong Attempt To Avoid Sorrento Litigation
10/9/2019 10:48:31 AM Sorrento Therapeutics Closes $25 Mln Registered Direct Offering
10/7/2019 2:36:17 PM Sorrento Therapeutics Announces $25 Mln Registered Direct Offering